

@article {3712,
	title = {Effectiveness of monovalent and pentavalent rotavirus vaccine.},
	journal = {Pediatrics},
	volume = {132},
	number = {1},
	year = {2013},
	pages = {e25{\textendash}e33},
	abstract = {Previous \{\{\}US\{\}\} evaluations have not assessed monovalent rotavirus vaccine \{\{\}(RV1,\{\}\} a \{\{\}G1P[8]\{\}\} human rotavirus strain) effectiveness, because of its later introduction (2008). Using case-control methodology, we measured the vaccine effectiveness \{\{\}(VE)\{\}\} of the 2-dose \{\{\}RV1\{\}\} and 3-dose pentavalent vaccine \{\{\}(RV5)\{\}\} series against rotavirus disease resulting in hospital emergency department or inpatient care.},
	doi = {10.1542/peds.2012-3804},
	url = {http://dx.doi.org/10.1542/peds.2012-3804},
	author = {Cortese, Margaret M and Immergluck, Lilly C and Held, Melissa and Jain, Shabnam and Chan, Trisha and Grizas, Alexandra P and Khizer, Saadia and Barrett, Carol and Quaye, Osbourne and Mijatovic-Rustempasic, Slavica and Gautam, Rashi and Bowen, Michael D and Moore, Jessica and Tate, Jacqueline E and Parashar, Umesh D and V{\'a}zquez, Marietta}
}
